Home

cases of myocarditis by year

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization  | NEJM
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM

Myocarditis Risk 17 Times Higher for Unvaccinated Patients Ages 12-30 Who  Get COVID-19 Than COVID-Vaccinated Patients
Myocarditis Risk 17 Times Higher for Unvaccinated Patients Ages 12-30 Who Get COVID-19 Than COVID-Vaccinated Patients

Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines |  tctmd.com
Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines | tctmd.com

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19  Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM

Israel reports very few myocarditis cases among 12-15 year olds after  booster | Reuters
Israel reports very few myocarditis cases among 12-15 year olds after booster | Reuters

JCM | Free Full-Text | Occurrence, Trends, Management and Outcomes of  Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year  Perspectives from the MYO-PL Nationwide Database
JCM | Free Full-Text | Occurrence, Trends, Management and Outcomes of Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year Perspectives from the MYO-PL Nationwide Database

Trends in myocarditis incidence, complications and mortality in Sweden from  2000 to 2014 | Scientific Reports
Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014 | Scientific Reports

Long-Term Outcome of Fulminant Myocarditis as Compared with Acute  (Nonfulminant) Myocarditis | NEJM
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis | NEJM

While rare, myocarditis after COVID-19 vaccination is more common in young  men
While rare, myocarditis after COVID-19 vaccination is more common in young men

Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis,  pathophysiology, therapy, and outcomes put into perspective. A clinical  consensus document supported by the Heart Failure Association of the  European Society of Cardiology (ESC ...
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ...

JPM | Free Full-Text | Myocarditis and Pericarditis following COVID-19  Vaccination: Inequalities in Age and Vaccine Types
JPM | Free Full-Text | Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types

KoreaMed Synapse
KoreaMed Synapse

Occurrence and Features of Childhood Myocarditis: A Nationwide Study in  Finland | Journal of the American Heart Association
Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association

Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac,  and ChAdOx1 among adolescent and adult in Malaysia - ScienceDirect
Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia - ScienceDirect

COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic  Uncertainty | Journal of the American College of Cardiology
COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic Uncertainty | Journal of the American College of Cardiology

CDC - An MMWR report finds that patients with COVID-19 had almost 16 times  the risk for myocarditis, or inflammation of part of the heart muscle,  compared with patients who did not
CDC - An MMWR report finds that patients with COVID-19 had almost 16 times the risk for myocarditis, or inflammation of part of the heart muscle, compared with patients who did not

Delayed-onset myocarditis following COVID-19 - The Lancet Respiratory  Medicine
Delayed-onset myocarditis following COVID-19 - The Lancet Respiratory Medicine

The Global Burden of Myocarditis: Part 1: A Systematic Literature Review  for the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study -  ScienceDirect
The Global Burden of Myocarditis: Part 1: A Systematic Literature Review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study - ScienceDirect

Association Between COVID-19 and Myocarditis Using Hospital-Based  Administrative Data — United States, March 2020–January 2021 | MMWR
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR